The research of P53 and BCL6 mutations in invasive breast carcinoma in the Cancer Genome Atlas (TCGA) portal showed that p53 presented 240 different mutations in 360 of 960 cases of invasive breast carcinomas, corresponding to 36.51% and BCL6 was mutated in 5 of 960 cases corresponding to 0.51% (Table 1). This evidence concerns the gene BCL6 and invasive breast carcinoma.